WASHINGTON, D.C. – Following a Congressional hearing on “Preparing for and Responding to Future Public Health Security Threats,” AdvaMed, The Medtech Association®, released a statement from President and CEO Scott Whitaker echoing the…
AdvaMed, The Medtech Association®, today called on the Biden Administration to implement a proposal to create a predictable pathway to national Medicare coverage for breakthrough medical technologies. The announcement comes…
AdvaMed, The Medtech Association®, urges the Environmental Protection Agency (EPA) to heed concerns of medtech supply shortfalls under its proposed requirements on ethylene oxide (EtO) sterilization and consider the effects…
AdvaMed®: “We place the highest priority on the safety of our communities, employees, and the millions of patients we serve.” WASHINGTON, D.C. – This week, medtech leaders from across the country…
Today, AdvaMed, The Medtech Association®, released the findings of a new national poll on radiation therapy and cancer treatment revealing broad support for greater federal investment in the proven cancer…
Following the introduction of the bipartisan American Innovation and Jobs Act in the U.S. Senate and its House companion the American Innovation and R&D Competitiveness Act, AdvaMed, The Medtech Association®,…
AdvaMed, The Medtech Association®, today called upon the U.S. Environmental Protection Agency (EPA) to double the time it will allow for public comment on two proposed updates to regulations governing…
AdvaMed, The Medtech Association®, working alongside the Department of Commerce’s International Trade Administration, advocated for and secured the recently implemented transition extensions for certifying medical devices in the European Union…
The Environmental Protection Agency (EPA) today released its proposed rule regulating ethylene oxide (EtO) sterilizers of medical technology and other commercial uses through the National Emission Standards for Hazardous Air…
AdvaMed, The Medtech Association®, recently commented on the FTC’s proposed rule that would ban employers from imposing or enforcing non-compete clauses in contracts with certain workers. AdvaMed® opposes the FTC’s vastly…